FDA approval in mid 2013 + Low float = Tgt $20-30 in 2013 // Pick of the Century
This Sleeping Giant will explode like a super novae once the investors discover this pure Goldmine ...Now is the time to load up the truck with the cheapis to sell them above $10++ on FDA approval ! GLTA
In early November, EDAP held a productive pre-PMA meeting with the U.S. FDA to discuss the PMA submission for the Company's Ablatherm-HIFU Phase II/III clinical trial for the indication of low risk, localized prostate cancer. Based on the guidance received in this FDA interaction, EDAP is finalizing its PMA file for submission in January 2013.